Check out the companies making headlines before the bell. Spotify — The streaming stock popped 7.4% after Spotify reported an increase in Premium subscribers — which reached 236 million in the fourth quarter — that beat analysts’ expectations as estimated by the FactSet consensus. Palantir — Shares of the data analytics provider surged more than 20% after the company on Monday reported $608.4 million in revenue for the quarter, versus the $602.4 million expected by analysts surveyed by LSEG. Earnings and guidance for 2024 was about in line with expectations. Eli Lilly — The drug maker saw its shares rise 4% after it blew past analysts’ estimates for the fourth quarter thanks to the strong launch of its weight loss drug Zepboud and higher prices for its diabetes drug Mounjaro. The compan y posted adjusted earnings of $2.49 per share on revenue of $9.35 billion. Analysts anticipated $2.22 per share on revenue of $8.93 billion, according to LSEG. Tesla — The beaten-down electric vehicle stock lost 2.3% after Daiwa downgraded Tesla to neutral from outperform, citing concerns around the company’s corporate governance and uncertainty around possible board or leadership changes. UBS — Shares dropped about 4.1% after the bank reported a second consecutive quarterly loss, as its revenue of $10.86 billion fell slightly short of analysts’ expectations per FactSet. The …
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnCheck out the companies making headlines before the bell. Spotify — The streaming stock popped 7.4% after Spotify reported an increase in Premium subscribers — which reached 236 million in the fourth quarter — that beat analysts’ expectations as estimated by the FactSet consensus. Palantir — Shares of the data analytics provider surged more than 20% after the company on Monday reported $608.4 million in revenue for the quarter, versus the $602.4 million expected by analysts surveyed by LSEG. Earnings and guidance for 2024 was about in line with expectations. Eli Lilly — The drug maker saw its shares rise 4% after it blew past analysts’ estimates for the fourth quarter thanks to the strong launch of its weight loss drug Zepboud and higher prices for its diabetes drug Mounjaro. The compan y posted adjusted earnings of $2.49 per share on revenue of $9.35 billion. Analysts anticipated $2.22 per share on revenue of $8.93 billion, according to LSEG. Tesla — The beaten-down electric vehicle stock lost 2.3% after Daiwa downgraded Tesla to neutral from outperform, citing concerns around the company’s corporate governance and uncertainty around possible board or leadership changes. UBS — Shares dropped about 4.1% after the bank reported a second consecutive quarterly loss, as its revenue of $10.86 billion fell slightly short of analysts’ expectations per FactSet. The …nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]
